Electrical Equipment & Parts
Compare Stocks
2 / 10Stock Comparison
AMPX vs CBAT
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
AMPX vs CBAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Electrical Equipment & Parts | Electrical Equipment & Parts |
| Market Cap | $2.29B | $71M |
| Revenue (TTM) | $90M | $162M |
| Net Income (TTM) | $-40M | $-7M |
| Gross Margin | 18.1% | 10.8% |
| Operating Margin | -23.4% | -10.5% |
| Forward P/E | — | 6.1x |
| Total Debt | $40M | $30M |
| Cash & Equiv. | $90M | $7M |
AMPX vs CBAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Amprius Technologie… (AMPX) | 100 | 181.1 | +81.1% |
| CBAK Energy Technol… (CBAT) | 100 | 68.7 | -31.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMPX vs CBAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AMPX is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 202.1%, EPS growth 22.2%, 3Y rev CAGR 154.9%
- 101.2% 10Y total return vs CBAT's -69.7%
- 202.1% revenue growth vs CBAT's -13.6%
CBAT carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 1.01
- Lower volatility, beta 1.01, Low D/E 25.1%, current ratio 0.82x
- Beta 1.01, current ratio 0.82x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 202.1% revenue growth vs CBAT's -13.6% | |
| Quality / Margins | -4.0% margin vs AMPX's -44.0% | |
| Stability / Safety | Beta 1.01 vs AMPX's 3.11, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +5.7% vs CBAT's -8.1% | |
| Efficiency (ROA) | -2.0% ROA vs AMPX's -28.0%, ROIC 4.6% vs -66.4% |
AMPX vs CBAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AMPX vs CBAT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CBAT leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CBAT is the larger business by revenue, generating $162M annually — 1.8x AMPX's $90M. CBAT is the more profitable business, keeping -4.0% of every revenue dollar as net income compared to AMPX's -44.0%. On growth, AMPX holds the edge at +152.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $90M | $162M |
| EBITDAEarnings before interest/tax | -$18M | -$8M |
| Net IncomeAfter-tax profit | -$40M | -$7M |
| Free Cash FlowCash after capex | -$59M | -$8M |
| Gross MarginGross profit ÷ Revenue | +18.1% | +10.8% |
| Operating MarginEBIT ÷ Revenue | -23.4% | -10.5% |
| Net MarginNet income ÷ Revenue | -44.0% | -4.0% |
| FCF MarginFCF ÷ Revenue | -65.1% | -5.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +152.9% | +36.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +49.6% | — |
Valuation Metrics
CBAT leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.3B | $71M |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $94M |
| Trailing P/EPrice ÷ TTM EPS | -47.71x | 6.08x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 5.25x |
| Price / SalesMarket cap ÷ Revenue | 31.34x | 0.40x |
| Price / BookPrice ÷ Book value/share | 20.05x | 0.59x |
| Price / FCFMarket cap ÷ FCF | — | 3.15x |
Profitability & Efficiency
CBAT leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
CBAT delivers a -5.5% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-40 for AMPX. CBAT carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMPX's 0.38x. On the Piotroski fundamental quality scale (0–9), CBAT scores 7/9 vs AMPX's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -40.4% | -5.5% |
| ROA (TTM)Return on assets | -28.0% | -2.0% |
| ROICReturn on invested capital | -66.4% | +4.6% |
| ROCEReturn on capital employed | -38.4% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.38x | 0.25x |
| Net DebtTotal debt minus cash | -$51M | $23M |
| Cash & Equiv.Liquid assets | $90M | $7M |
| Total DebtShort + long-term debt | $40M | $30M |
| Interest CoverageEBIT ÷ Interest expense | — | -24.86x |
Total Returns (Dividends Reinvested)
AMPX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMPX five years ago would be worth $20,120 today (with dividends reinvested), compared to $2,129 for CBAT. Over the past 12 months, AMPX leads with a +570.7% total return vs CBAT's -8.1%. The 3-year compound annual growth rate (CAGR) favors AMPX at 22.9% vs CBAT's 0.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +91.1% | -8.1% |
| 1-Year ReturnPast 12 months | +570.7% | -8.1% |
| 3-Year ReturnCumulative with dividends | +85.6% | +2.6% |
| 5-Year ReturnCumulative with dividends | +101.2% | -78.7% |
| 10-Year ReturnCumulative with dividends | +101.2% | -69.7% |
| CAGR (3Y)Annualised 3-year return | +22.9% | +0.9% |
Risk & Volatility
Evenly matched — AMPX and CBAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBAT is the less volatile stock with a 1.01 beta — it tends to amplify market swings less than AMPX's 3.11 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMPX currently trades 73.2% from its 52-week high vs CBAT's 63.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.11x | 1.01x |
| 52-Week HighHighest price in past year | $22.80 | $1.25 |
| 52-Week LowLowest price in past year | $2.32 | $0.77 |
| % of 52W HighCurrent price vs 52-week peak | +73.2% | +63.2% |
| RSI (14)Momentum oscillator 0–100 | 40.2 | 38.4 |
| Avg Volume (50D)Average daily shares traded | 9.2M | 110K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $18.50 | — |
| # AnalystsCovering analysts | 12 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CBAT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). AMPX leads in 1 (Total Returns). 1 tied.
AMPX vs CBAT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is AMPX or CBAT a better buy right now?
For growth investors, Amprius Technologies, Inc.
(AMPX) is the stronger pick with 202. 1% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. Analysts rate Amprius Technologies, Inc. (AMPX) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — AMPX or CBAT?
Over the past 5 years, Amprius Technologies, Inc.
(AMPX) delivered a total return of +101. 2%, compared to -78. 7% for CBAK Energy Technology, Inc. (CBAT). Over 10 years, the gap is even starker: AMPX returned +101. 2% versus CBAT's -69. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — AMPX or CBAT?
By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.
(CBAT) is the lower-risk stock at 1. 01β versus Amprius Technologies, Inc. 's 3. 11β — meaning AMPX is approximately 209% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 38% for Amprius Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — AMPX or CBAT?
By revenue growth (latest reported year), Amprius Technologies, Inc.
(AMPX) is pulling ahead at 202. 1% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to 22. 2% for Amprius Technologies, Inc.. Over a 3-year CAGR, AMPX leads at 154. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — AMPX or CBAT?
CBAK Energy Technology, Inc.
(CBAT) is the more profitable company, earning 6. 7% net margin versus -60. 3% for Amprius Technologies, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBAT leads at 5. 0% versus -63. 9% for AMPX. At the gross margin level — before operating expenses — CBAT leads at 23. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — AMPX or CBAT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is AMPX or CBAT better for a retirement portfolio?
For long-horizon retirement investors, CBAK Energy Technology, Inc.
(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01)). Amprius Technologies, Inc. (AMPX) carries a higher beta of 3. 11 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 7%, AMPX: +101. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between AMPX and CBAT?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AMPX is a small-cap high-growth stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.